Catalyst Wire Dossier Catalyst Wire Dossier

Imatinib Mesylate Tablet 400 mg

imatinib · Dong-A ST Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imatinib Mesylate Tablet 400 mg, covering 2014-10-01 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) [Phase 1]

See pricing